Humanised monoclonal antibodies neutralise pertussis toxin by receptor blockade and reduced retrograde trafficking

Cellular Microbiology
Edith Acquaye-SeedahJennifer A Maynard

Abstract

Pertussis toxin (PTx) is a major protective antigen produced by Bordetella pertussis that is included in all current acellular vaccines. Of several well-characterized monoclonal antibodies binding this toxin, the humanised hu1B7 and hu11E6 antibodies are highly protective in multiple in vitro and in vivo assays. In this study, we determine the molecular mechanisms of protection mediated by these antibodies. Neither antibody directly binds the B. pertussis bacterium nor supports antibody-dependent complement cytotoxicity. Both antibodies, either individually or as a cocktail, form multivalent complexes with soluble PTx that bind the FcγRIIb receptor more tightly than antibody alone, suggesting that the antibodies may accelerate PTx clearance via immune complex formation. However, a receptor binding assay and cellular imaging indicate that the main mechanism used by hu11E6 is competitive inhibition of PTx binding to its cellular receptor. In contrast, the main hu1B7 neutralising mechanism appears to be inhibition of PTx internalisation and retrograde trafficking. We assessed the effects of hu1B7 on PTx retrograde trafficking in CHO-K1 cells using quantitative immunofluorescence microscopy. In the absence of hu1B7 or after incubat...Continue Reading

References

Apr 1, 1987·Infection and Immunity·H SatoI Ohishi
Jan 1, 1986·The Journal of Cell Biology·B van DeursS Olsnes
May 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·T Katada, M Ui
Jan 1, 1997·Annual Review of Immunology·M Daëron
May 12, 2001·FEMS Microbiology Reviews·A M SmithM J Walker
May 22, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L D SenziletUNKNOWN Sentinel Health Unit Surveillance System Pertussis Working Group
Dec 19, 2001·Infection and Immunity·Michael G Barnes, Alison A Weiss
Aug 23, 2003·The Journal of Infectious Diseases·Sandra M M HellwigFrits R Mooi
Dec 11, 2003·JAMA : the Journal of the American Medical Association·Masahiro TanakaTrudy V Murphy
Nov 24, 2004·Infection and Immunity·Alison A WeissDavid I Bernstein
Nov 19, 2005·The Journal of Clinical Investigation·Girish S KirimanjeswaraEric T Harvill
Jan 11, 2007·Journal of Microscopy·S Bolte, F P Cordelières
Jan 19, 2008·Cellular Microbiology·Roger D Plaut, Nicholas H Carbonetti
Feb 21, 2008·Infection and Immunity·Greice Krautz-PetersonAbhineet S Sheoran
Jan 24, 2009·The Pediatric Infectious Disease Journal·John B RobbinsBirger Trollfors
Mar 7, 2009·The Journal of Biological Chemistry·Phillip A Vanlandingham, Brian P Ceresa
Mar 6, 2010·Trends in Biochemical Sciences·Travis BeddoeJames C Paton
Mar 23, 2011·Proceedings of the National Academy of Sciences of the United States of America·Jennie S LavineOttar N Bjørnstad
Oct 12, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Latha P GanesanClark L Anderson
Apr 30, 2013·Journal of Biochemistry·Tomohiko Taguchi
May 15, 2013·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Somshuvra Mukhopadhyay, Adam D Linstedt
Jun 14, 2013·Molecular Biology of the Cell·Somshuvra MukhopadhyayAdam D Linstedt

❮ Previous
Next ❯

Methods Mentioned

BETA
flow cytometry
ELISA
confocal microscopy
ELISAs

Software Mentioned

FlowJo
JACoP
ImageJ
GraphPad Prism
GraphPad

Related Concepts

Related Feeds

Antibodies: Agglutination

Antibody-mediated agglutination is the clumping of cells in the presence of antibody, which binds multiple cells together. This enhances the clearance of pathogens. Find the latest research on antibody-mediated agglutination here.